» Articles » PMID: 36839394

Nutritional Approaches to Modulate Cardiovascular Disease Risk in Systemic Lupus Erythematosus: A Literature Review

Overview
Journal Nutrients
Date 2023 Feb 25
PMID 36839394
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic lupus erythematosus (SLE) is a chronic pathology characterized by a bimodal mortality pattern attributed to clinical disease activity and cardiovascular disease (CVD). A complex interaction between traditional CVD risk factors such as obesity, dyslipidemia, smoking, insulin resistance, metabolic syndrome, and hypertension, as well as the presence of non-traditional CVD risk factors such as hyperhomocysteinemia, pro-inflammatory cytokines, and C-reactive protein levels, has been suggested as a cause of the high prevalence of CVD in SLE patients. On the other hand, environmental factors, such as nutritional status, could influence the disease's prognosis; several nutrients have immunomodulators, antioxidants, and anti-cardiometabolic risk properties which could reduce SLE severity and organ damage by decreasing the development of traditional and non-traditional CVD risk factors. Therefore, this critical literature review discusses the therapeutic potential of nutritional approaches that could modulate the development of the main comorbidities related to CVD risk in SLE patients.

Citing Articles

Body mass index and fat influences the role of genus in lupus patients concerning fibrinogen levels.

Chero-Sandoval L, Higuera-Gomez A, Cuevas-Sierra A, de Cuevillas B, Castejon R, Martinez-Urbistondo M Front Microbiol. 2024; 15:1471177.

PMID: 39654674 PMC: 11625790. DOI: 10.3389/fmicb.2024.1471177.


Managing Cardiovascular Risk in Patients with Autoimmune Diseases: Insights from a Nutritional Perspective.

Chen H, Liu L, Wang Y, Hong L, Pan J, Yu X Curr Nutr Rep. 2024; 13(4):718-728.

PMID: 39078574 DOI: 10.1007/s13668-024-00563-7.


No Changes in Body Composition and Adherence to the Mediterranean Diet after a 12-Week Aerobic Training Intervention in Women with Systemic Lupus Erythematosus: The EJERCITA-LES Study.

Gavilan-Carrera B, Ruiz-Cobo A, Amaro-Gahete F, Soriano-Maldonado A, Vargas-Hitos J Nutrients. 2023; 15(20).

PMID: 37892499 PMC: 10609990. DOI: 10.3390/nu15204424.


Plasma Zonulin, and Sodium Intake Affect C3 Complement Levels in Inactive Systemic Lupus Erythematosus.

Balmant B, Fonseca D, Aguiar Prudencio A, Rocha I, Callado L, Tepedino Martins Alves J Nutrients. 2023; 15(8).

PMID: 37111218 PMC: 10144636. DOI: 10.3390/nu15081999.

References
1.
Perez De Lema G, Lucio-Cazana F, Molina A, Luckow B, Schmid H, De Wit C . Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease. Kidney Int. 2004; 66(3):1018-28. DOI: 10.1111/j.1523-1755.2004.00850.x. View

2.
Santos F, Curado Borges M, Telles R, Correia M, Lanna C . Excess weight and associated risk factors in patients with systemic lupus erythematosus. Rheumatol Int. 2012; 33(3):681-8. DOI: 10.1007/s00296-012-2402-8. View

3.
Varghese B, Haase N, Low P . Depletion of folate-receptor-positive macrophages leads to alleviation of symptoms and prolonged survival in two murine models of systemic lupus erythematosus. Mol Pharm. 2007; 4(5):679-85. DOI: 10.1021/mp0700615. View

4.
Bell J, Hamer M, Batty G, Singh-Manoux A, Sabia S, Kivimaki M . Combined effect of physical activity and leisure time sitting on long-term risk of incident obesity and metabolic risk factor clustering. Diabetologia. 2014; 57(10):2048-56. PMC: 4153972. DOI: 10.1007/s00125-014-3323-8. View

5.
Hermansen M, Lindhardsen J, Torp-Pedersen C, Faurschou M, Jacobsen S . Incidence of Systemic Lupus Erythematosus and Lupus Nephritis in Denmark: A Nationwide Cohort Study. J Rheumatol. 2016; 43(7):1335-9. DOI: 10.3899/jrheum.151221. View